Wockhardt presents a compelling proposition for strategic acquisition. The company's diverse portfolio of pharmaceutical products, coupled with its solid presence in both domestic and international markets, makes it an attractive target for strategic investors. Analysts suggest that Wockhardt's skillset in key therapeutic areas, such as anti-infec